Phibro Animal Health Corporation Financial Ratios — PB8

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Return on Common Equity (%)	- -	- -	- -	269.25	137.76	53.48	38.61	27.29	16.6	25.49	19.63	11.97	0.9	17.8	29.72
Return on Assets (%)	- -	5.44	-0.66	12.48	15.03	10.5	10.02	7.83	4.44	6.69	5.55	3.43	0.25	4.12	6.97
Return on Capital (%)	- -	- -	-6.5	22.9	- -	17.27	15.44	12.54	7.34	10.14	8.21	5.69	0.92	7.86	11.86
Return on Invested Capital (%)	- -	- -	-10.55	21.65	- -	17.49	15.25	12.26	7.32	9.67	7.65	5.64	1.49	8.54	12.56
Gross Margin (%)	25.09	27.4	29.54	31.16	31.81	32.48	32.55	31.96	32.1	32.56	30.29	30.5	30.77	30.85	33.76
EBITDA Margin (%)	10.22	11.6	12.32	14.6	14.5	16.22	15.35	13.38	12.69	12.81	11.85	10.83	8.79	12.04	16.2
Operating Margin (%)	7.54	8.69	9.22	11.71	11.41	12.81	12.06	10.05	8.65	8.98	8.38	7.35	5.24	8.52	12.81
Incremental Operating Margin (%)	22.62	- -	18.22	42.12	- -	95.57	1.78	- -	50.77	17.2	3.78	- -	- -	20.52	37.83
Pretax Margin (%)	2	2.73	0.91	10.52	10.21	10.54	10.74	8.64	6.94	7.98	7.68	5.53	1.07	5.25	9.05
Profit Margin (%)	1.07	3.81	-0.45	8.05	11.01	8.45	7.91	6.61	4.19	6.53	5.22	3.33	0.24	3.72	6.57
Net Income to Common Margin (%)	1.07	3.81	-0.45	8.05	11.01	8.45	7.91	6.61	4.19	6.53	5.22	3.33	0.24	3.72	6.57
Effective Tax Rate (%)	46.8	- -	149.57	23.47	- -	19.78	26.33	23.48	39.56	18.18	32.01	39.7	77.87	29.02	27.4
Dvd Payout Ratio (%)	- -	12.05	-799.49	25.87	18.99	24.49	24.77	33.98	57.87	35.73	39.54	59.63	804.72	40.3	19.52
Sustainable Growth Rate (%)	- -	- -	- -	199.59	111.6	40.38	29.04	18.02	6.99	16.38	11.87	4.83	-6.32	10.63	23.92

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Total Debt	350	366	289	290	350	313	312	326	411	427	470	510	525	762	789
ST Debt	5	- -	3	3	3	6	13	13	25	16	21	28	37	25	36
LT Debt	345	366	286	287	347	307	300	314	386	411	449	482	488	736	753
Total Debt/EBITDA	5.24	4.83	3.39	2.65	3.21	2.53	2.48	2.94	4.05	4	4.21	4.82	5.87	4.88	3.21
Net Debt/EBITDA	4.43	4.46	3.26	2.38	2.91	2.07	2.25	2.42	3.45	3.2	3.21	4.1	4.66	4.17	2.73
Total Debt/EBIT	7.1	6.44	4.54	3.3	4.08	3.2	3.16	3.92	5.94	5.7	5.96	7.1	9.86	6.89	4.06
Net Debt/EBIT	6.01	5.96	4.35	2.97	3.69	2.62	2.86	3.23	5.07	4.57	4.54	6.03	7.83	5.89	3.45
EBITDA to Interest Expense	1.87	2.12	2.58	7.51	6.47	7.35	9.9	8.1	7.39	9	9.23	5.9	4.07	4.69	5.58
EBITDA-CapEx/Interest Expense	1.87	2.12	2.58	7.51	6.47	7.35	9.9	8.1	7.39	9	9.23	5.9	4.07	4.69	5.58
EBIT to Interest Expense	1.38	1.59	1.93	6.02	5.09	5.8	7.78	6.09	5.04	6.31	6.53	4	2.43	3.32	4.41
Interest Expense	36	36	33	15	17	17	13	14	14	12	12	18	22	33	44
Common Equity/Total Assets	-20.01	-14.54	3.21	6.01	14.89	24.25	27.54	29.73	24	28.35	28.17	29.08	26.13	20.99	25.68
Long-Term Debt/Equity (%)	- -	- -	1,890.7	967.7	383.8	203.03	162.1	145.19	204.85	172.19	171.25	170.48	190.23	257.69	195.39
Long-Term Debt/Capital (%)	131.65	123.22	94.05	89.84	78.81	66.1	60.28	57.85	64.37	61.74	61.32	60.77	62.42	70.3	64.14
Long-Term Debt/Total Assets (%)	78.2	77.1	60.64	58.12	57.13	49.23	44.63	43.16	49.17	48.82	48.24	49.58	49.71	54.09	50.17
Total Debt/Equity (%)	-396.84	-530.34	1,910.3	977.18	387.02	207.16	168.9	151	218.23	178.89	179.27	180.51	204.74	266.57	204.62
Total Debt/Capital (%)	133.69	123.24	95.03	90.72	79.47	67.44	62.81	60.16	68.58	64.14	64.19	64.35	67.19	72.72	67.17
Total Debt/Total Assets (%)	79.41	77.11	61.27	58.69	57.61	50.23	46.51	44.89	52.38	50.72	50.5	52.5	53.5	55.96	52.54
Net Debt to Equity	-335.74	-490.64	1,832.27	878.57	349.88	170.06	153.13	124.34	186.32	143.33	136.67	153.47	162.67	227.75	174.17
Net Debt/Capital (%)	142.42	125.6	94.82	89.78	77.77	62.97	60.49	55.43	62.33	55.59	54.45	57.72	58.68	66.45	60.33
EBITDA	67	76	85	109	109	124	126	111	102	107	112	106	89	156	246
EBITDA-CapEx	67	76	85	109	109	124	126	111	102	107	112	106	89	156	246
Operating Income (Loss)	49	57	64	88	86	98	99	83	69	75	79	72	53	110	194

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Cash Ratio	0.43	0.24	0.11	0.26	0.31	0.48	0.55	0.53	0.58	0.57	0.48	0.46	0.56	0.26	0.26
Current Ratio	2.4	2.57	2.66	2.82	3.15	3.14	2.9	3.02	2.87	3.04	2.97	3.33	2.94	2.76	2.96
Quick Ratio	1.22	1.1	1.12	1.26	1.45	1.57	1.5	1.56	1.39	1.46	1.35	1.39	1.39	1.04	1.01
CFO/Avg Current Liab	- -	0.01	-0.01	0.61	0.34	0.88	0.54	0.32	0.38	0.3	0.18	0.07	0.46	0.32	0.23
Common Equity/Total Assets	-20.01	-14.54	3.21	6.01	14.89	24.25	27.54	29.73	24	28.35	28.17	29.08	26.13	20.99	25.68
Long-Term Debt/Equity (%)	- -	- -	1,890.7	967.7	383.8	203.03	162.1	145.19	204.85	172.19	171.25	170.48	190.23	257.69	195.39
Long-Term Debt/Capital (%)	131.65	123.22	94.05	89.84	78.81	66.1	60.28	57.85	64.37	61.74	61.32	60.77	62.42	70.3	64.14
Long-Term Debt/Total Assets (%)	78.2	77.1	60.64	58.12	57.13	49.23	44.63	43.16	49.17	48.82	48.24	49.58	49.71	54.09	50.17
Total Debt/Equity (%)	-396.84	-530.34	1,910.3	977.18	387.02	207.16	168.9	151	218.23	178.89	179.27	180.51	204.74	266.57	204.62
Total Debt/Capital (%)	133.69	123.24	95.03	90.72	79.47	67.44	62.81	60.16	68.58	64.14	64.19	64.35	67.19	72.72	67.17
Total Debt/Total Assets (%)	79.41	77.11	61.27	58.69	57.61	50.23	46.51	44.89	52.38	50.72	50.5	52.5	53.5	55.96	52.54
CFO/Total Liabilities	6.05	0.26	-0.16	14.82	7.19	20.83	14.38	9.24	9.96	8.01	4.73	1.93	12.07	7.45	6.18
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	3.52	3.61	3.14	2.87	2.85	2.69	3.1

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Accounts Receivable Turnover	- -	6.59	6.5	6.66	6.4	6.12	6.27	5.62	5.61	6.1	6.01	5.93	6.11	6.52	6.5
Days Sales Outstanding	- -	55.4	56.18	54.84	57.04	59.61	58.22	64.97	65.11	59.87	60.7	61.59	59.7	55.96	56.11
Inventory Turnover	- -	3.65	3.44	3.52	3.23	3.14	3.26	2.99	2.75	2.72	2.76	2.53	2.59	2.52	2.05
Days Inventory Outstanding	- -	100.13	106.02	103.76	113.05	116.33	111.99	121.96	132.64	134.11	132.1	144.12	140.77	144.64	177.73
Accounts Payable Turnover	- -	7.85	8.35	8.51	8.61	8.71	9.8	8.8	7.78	8.65	8.54	8.24	8.69	9.61	8.26
Accounts Payable Turnover Days	- -	46.48	43.71	42.89	42.4	41.92	37.26	41.5	46.91	42.19	42.76	44.3	41.99	38	44.21
Cash Conversion Cycle	- -	109.05	118.5	115.71	127.69	134.01	132.95	145.43	150.83	151.79	150.04	161.41	158.49	162.6	189.64
Inventory to Cash Days	- -	-44.72	-49.84	-48.91	-56.01	-56.72	-53.77	-56.99	-67.53	-74.24	-71.4	-82.53	-81.07	-88.68	-121.62
Inventories	120	140	143	150	168	161	178	198	197	216	259	278	266	444	535
Raw Materials	35	37	44	40	51	55	62	64	74	60	87	84	73	163	195
Work In Process	6	8	8	8	8	12	15	11	9	13	15	22	24	28	27
Finished Goods	79	96	91	102	108	94	101	123	114	144	157	171	170	254	313
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	1,027	1,153	764	544	690	1,041	1,288
- Cash & Cash Equivalents	54	27	12	29	34	56	29	58	36	50	74	41	71	68	61
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	350	366	289	290	350	313	312	326	411	427	470	510	525	762	789
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	1,346	1,487	1,143	972	1,101	1,726	1,995
Total Capital	262	297	305	319	441	464	497	542	599	665	733	792	782	1,047	1,174
Total Debt/Capital (%)	133.69	123.24	95.03	90.72	79.47	67.44	62.81	60.16	68.58	64.14	64.19	64.35	67.19	72.72	67.17
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.31	0.29	0.41	0.52	0.48	0.44	0.4
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	1.68	1.78	1.21	0.99	1.08	1.33	1.31
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	13.26	13.93	10.24	9.18	12.3	11.06	8.11
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	19.46	19.86	14.48	13.53	20.65	15.62	10.26
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	19.9	25.63	28.67	40.29	11.91	16.64	19.76
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	19.9	25.63	28.67	40.29	11.91	16.64	19.76
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	1,028	1,153	764	544	691	1,045	1,301
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	1,348	1,487	1,143	972	1,101	1,730	2,008
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	33.28	36.71	28.23	24	27.18	42.58	49.18
TTM Sales	654	653	692	749	752	764	820	828	800	833	942	978	1,018	1,296	1,518
TTM EBITDA	67	76	85	109	109	124	126	111	102	107	112	106	89	156	246
TTM Operating Income	49	57	64	88	86	98	99	83	69	75	79	72	53	110	194
TTM Cash Flow to Firm	51	- -	-17	80	- -	112	79	58	68	58	40	24	92	104	101
TTM Free Cash Flow to Firm	51	- -	-17	80	- -	112	79	58	68	58	40	24	92	104	101

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	17.32	23.87	24.14	40.84	7.88	13.04	18.87
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	19.46	19.86	14.48	13.53	20.65	15.62	10.26
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	1,346	1,487	1,143	972	1,101	1,726	1,995
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	17.06	16.18	17.54	11.88	9.42	16.15	25.27
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	1.68	1.78	1.21	0.99	1.08	1.33	1.31
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	13.26	13.93	10.24	9.18	12.3	11.06	8.11
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	30.64	21.2	15.54	16.67	285.67	21.57	12.91
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	28.66	16.38	17.19	18.42	220.73	18.14	16.51
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	34.64	22.02	24.43	24.71	307.76	22.1	24.22
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	20.59	12.05	14.44	14.76	157.87	13.55	10.27
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	5.46	4.83	2.91	1.92	2.69	3.65	3.34
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	5.1	3.73	3.22	2.13	2.08	3.07	4.27
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	6.17	5.02	4.58	2.85	2.9	3.73	6.27
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	3.67	2.75	2.71	1.7	1.49	2.29	2.66
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	15.92	9.33	5.26	3.12	4.39	5.49	4.36
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	14.88	7.21	5.82	3.45	3.4	4.62	5.58
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	17.99	9.69	8.27	4.62	4.73	5.63	8.18
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	10.7	5.3	4.89	2.76	2.43	3.45	3.47
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	1.28	1.38	0.81	0.56	0.68	0.8	0.85
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	1.2	1.07	0.9	0.61	0.52	0.68	1.08
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	1.45	1.44	1.28	0.82	0.73	0.82	1.59
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	0.86	0.79	0.75	0.49	0.37	0.5	0.67
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	17.32	23.87	24.14	40.84	7.88	12.99	18.68
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	16.2	18.44	26.71	45.12	6.09	10.93	23.88
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	19.59	24.79	37.96	60.54	8.49	13.31	35.03
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	11.64	13.57	22.44	36.15	4.35	8.16	14.86
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	16.2	18.44	26.71	45.12	6.09	10.97	24.12
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	19.59	24.79	37.96	60.54	8.49	13.36	35.39
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	11.64	13.57	22.44	36.15	4.36	8.2	15.01
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	1.6	1.47	1.3	1.05	0.93	1.2	1.55
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	1.85	1.84	1.68	1.26	1.13	1.35	2.06
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	1.26	1.19	1.16	0.93	0.78	1.03	1.14
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	12.6	11.47	10.97	9.72	10.55	10	9.57
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	14.58	14.34	14.15	11.66	12.9	11.22	12.7
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	9.94	9.26	9.75	8.59	8.85	8.58	7.04
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	18.5	16.35	15.51	14.33	17.71	14.13	12.11
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	21.39	20.45	20.01	17.18	21.65	15.86	16.07
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	14.59	13.21	13.79	12.66	14.86	12.12	8.91
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	25.39	28.47	18.87	13.42	17.04	25.69	31.76
High Price	- -	- -	- -	- -	- -	- -	- -	- -	28.7	29.57	29.67	19.89	18.36	26.32	59.57
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	1,280	1,224	1,225	1,029	944	1,560	2,354
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	1,480	1,531	1,581	1,234	1,154	1,752	3,123
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	1,010	989	1,090	910	792	1,339	1,732

Shares Outstanding	39	39	39	39	39	40	40	40	40	41	41	41	41	41	41
Diluted Weighted Avg Shares	31	30	32	40	40	40	40	41	41	41	41	41	41	41	41
Basic Weighted Avg Shares	30	30	32	39	39	40	40	40	41	41	41	41	41	41	41
Revenue per Share	21.48	21.44	21.49	19.21	19.12	19.35	20.4	20.49	19.76	20.58	23.27	24.14	25.13	31.99	37.44
EBITDA per Share	2.19	2.49	2.65	2.8	2.77	3.14	3.13	2.74	2.51	2.64	2.76	2.61	2.21	3.85	6.06
Operating Income per Share	1.62	1.86	1.98	2.25	2.18	2.48	2.46	2.06	1.71	1.85	1.95	1.77	1.32	2.73	4.79
Basic EPS, GAAP	0.23	0.82	-0.1	1.55	2.11	1.64	1.61	1.35	0.83	1.34	1.21	0.81	0.06	1.19	2.46
Basic EPS from Cont Ops	0.23	0.82	-0.1	1.55	2.11	1.64	1.61	1.35	0.83	1.34	1.21	0.81	0.06	1.19	2.46
Diluted EPS, GAAP	0.23	0.82	-0.1	1.51	2.07	1.62	1.61	1.35	0.83	1.34	1.21	0.81	0.06	1.19	2.43
Diluted EPS from Cont Ops	0.23	0.82	-0.1	1.51	2.07	1.62	1.61	1.35	0.83	1.34	1.21	0.81	0.06	1.19	2.43
Dividend per Share	- -	0.1	0.78	0.4	0.4	0.4	0.4	0.46	0.48	0.48	0.48	0.48	0.48	0.48	0.48
Cash Flow per Share	1.05	0.05	-0.02	1.76	0.95	2.49	1.74	1.17	1.47	1.19	0.78	0.33	2.16	1.98	1.7
Free Cash Flow per Basic Share	1.05	0.05	-0.02	1.76	0.95	2.49	1.74	1.17	1.47	1.19	0.78	0.33	2.16	1.98	1.7
Cash & Equivalents per Share	1.39	0.71	0.3	0.75	0.85	1.41	1.96	2.02	2.26	2.3	2.25	2.01	2.83	1.9	2.02
Book Value per Share	-2.27	-1.78	0.39	0.76	2.3	3.79	4.58	5.34	4.65	5.89	6.48	6.97	6.34	7.05	9.5
Tangible Book Value per Share	-2.71	-3.01	-0.7	-0.52	0.24	1.82	2.62	3.49	1.6	3.05	3.59	4.3	3.88	4.68	7.28

Phibro Animal Health Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)